Diabetic retinopathy cannot be cured in the traditional sense, but its earliest stages can be reversed with proper blood sugar control, and more advanced stages can be effectively managed to preserve vision. The distinction matters: once the disease progresses beyond mild changes in the retinal blood vessels, the goal shifts from reversal to slowing or stopping further damage. Most people with diabetic retinopathy can maintain functional vision with timely treatment.
Early Stages Can Be Reversed
In the initial stages of diabetic retinopathy, the tiny blood vessels in the retina develop small bulges and begin to leak fluid. At this point, the damage is not permanent. Achieving and maintaining tight blood sugar control can allow these early changes to resolve on their own. This is the closest thing to a “cure” that currently exists for the condition.
The evidence for blood sugar’s role is striking. The landmark Diabetes Control and Complications Trial found that a 10% reduction in HbA1c (for example, dropping from 8% to 7.2%) was associated with a 43% to 45% lower risk of retinopathy developing or getting worse. That relationship held across the entire range of HbA1c values tested, meaning every incremental improvement in blood sugar control translates to measurably less risk. Blood pressure matters too. Keeping blood pressure below 130/75 mm Hg is recommended for anyone who already shows signs of retinopathy, since high blood pressure independently accelerates damage to retinal blood vessels.
The catch is that early diabetic retinopathy rarely causes noticeable symptoms. Most people don’t realize anything is wrong until the disease has progressed. This is why annual dilated eye exams are critical for anyone with diabetes. AI-powered screening tools are increasingly being used in primary care settings to flag retinopathy earlier, with some algorithms achieving sensitivity above 99% for detecting the presence of disease.
What Happens When It Progresses
Once diabetic retinopathy advances to a more severe stage, the damage to retinal blood vessels becomes permanent. In proliferative diabetic retinopathy, the most advanced form, the eye grows fragile new blood vessels that can bleed into the interior of the eye or pull on the retina. At this point, treatment can stabilize or improve vision, but it cannot undo the structural changes that have already occurred. The condition becomes something you manage long-term rather than something you recover from.
The same applies to diabetic macular edema, a common complication where fluid leaks into the central part of the retina responsible for sharp, detailed vision. Even with aggressive treatment, only about 59% of patients see the swelling fully resolve within the first year. By the second year, that number reaches roughly 74%, meaning about one in four patients still has persistent edema despite ongoing care.
How Injections Help Preserve Vision
The current standard treatment for both advanced diabetic retinopathy and macular edema involves injections of medication directly into the eye. These drugs block a protein called VEGF that drives the growth of abnormal blood vessels and fluid leakage. The injections are typically given monthly, at least initially, and can meaningfully improve vision. In patients with proliferative disease, those receiving injections gained about 4 additional letters on a standard eye chart compared to those treated with laser therapy alone after one year.
The trade-off is that these injections are not a one-time fix. They need to be repeated regularly, sometimes for years. Stopping treatment, even after vision has stabilized, can lead to rapid worsening. From a pharmacological standpoint, monthly injections are needed to maintain adequate drug levels in the eye. Some patients transition to less frequent schedules over time, receiving injections every few months based on how their eyes respond, but the need for ongoing monitoring and retreatment rarely goes away entirely.
Laser Therapy and Surgery
Laser treatment, known as panretinal photocoagulation, has been used for decades to treat proliferative diabetic retinopathy. It works by sealing off leaking blood vessels and destroying areas of the retina that are producing the signals for abnormal vessel growth. It is effective at preventing severe vision loss, but it comes with trade-offs: the procedure can cause reductions in peripheral vision, difficulty with night vision, and occasionally swelling in the central retina.
For the most advanced cases, where bleeding fills the inside of the eye or the retina has begun to detach, surgery called vitrectomy may be necessary. Long-term studies show that about two-thirds of patients undergoing vitrectomy for proliferative disease achieved functional visual acuity in the operated eye after 10 years. When looking at overall visual function across both eyes, 86% of patients maintained relatively good vision in at least one eye after five years, and only about 3% experienced blindness in both eyes. These numbers reflect a disease that, while serious, is far from a guaranteed path to blindness when treated.
Gene Therapy on the Horizon
Several gene therapies are currently in clinical trials that could fundamentally change how diabetic retinopathy is treated. The goal is to deliver a one-time injection that programs cells in the eye to continuously produce their own anti-VEGF proteins, potentially eliminating the need for repeated injections. Three leading candidates are in Phase 2 or Phase 2/3 trials. One uses a viral vector to deliver a gene encoding a protein similar to existing anti-VEGF drugs, while another takes a dual approach by targeting two different growth factors simultaneously. These therapies are still years from potential approval, but early results have been encouraging.
What Determines Your Outcome
The single biggest factor in how diabetic retinopathy affects your vision over time is how early it’s caught. People diagnosed in the early, reversible stage who achieve good blood sugar and blood pressure control may never need eye injections or laser treatment at all. Those diagnosed later face a more intensive treatment path but still have a strong chance of preserving useful vision. The combination of consistent blood sugar management, regular eye exams, and prompt treatment when needed gives most people with diabetic retinopathy a realistic path to keeping their sight, even if the disease itself is never fully cured.